Prelude Therapeutics (PRLD) Stock Chart & Stock Price History $0.95 -0.01 (-1.11%) As of 01:27 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Prelude Therapeutics Stock Price Performance 5 Day Performance+5.34%1 Month Performance+23.20%3 Month Performance-13.73%6 Month Performance-23.47%Year-To-Date Performance-25.57%1 Year Performance-74.56% Receive PRLD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address PRLD Stock Chart for Thursday, May, 1, 2025 PRLD Chart by TradingView Prelude Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/30/2025$0.90$0.96+6.56%$0.98$0.85141,377 shs$54.20 million04/29/2025$0.89$0.90+1.61%$0.92$0.8552,754 shs$50.86 million04/28/2025$0.90$0.89-1.59%$0.93$0.8543,239 shs$50.05 million04/25/2025$0.86$0.90+4.56%$0.95$0.82109,271 shs$50.86 million04/24/2025$0.88$0.86-2.45%$0.89$0.83114,977 shs$48.64 million04/23/2025$0.94$0.88-5.91%$0.95$0.8599,145 shs$49.86 million04/22/2025$0.80$0.94+17.53%$0.94$0.82179,962 shs$52.99 million04/21/2025$0.81$0.80-1.40%$0.85$0.7876,846 shs$45.09 million04/18/2025$0.81$0.81$0.86$0.75205,948 shs$44.68 million04/17/2025$0.77$0.81+5.19%$0.86$0.75205,948 shs$44.68 million Get the Latest News and Ratings for PRLD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/16/2025$0.75$0.77+2.35%$0.80$0.72160,868 shs$42.47 million04/15/2025$0.69$0.75+8.40%$0.77$0.69133,621 shs$41.49 million04/14/2025$0.71$0.69-2.01%$0.72$0.66166,479 shs$38.28 million04/11/2025$0.64$0.71+10.35%$0.71$0.64190,863 shs$39.06 million04/10/2025$0.66$0.64-3.45%$0.68$0.63147,619 shs$35.40 million04/09/2025$0.61$0.66+8.88%$0.69$0.61163,290 shs$36.66 million04/09/2025$0.61$0.66+8.88%$0.69$0.61163,290 shs$36.66 million04/08/2025$0.65$0.61-5.80%$0.69$0.61197,204 shs$33.67 million04/08/2025$0.65$0.61-5.80%$0.69$0.61197,204 shs$33.67 million04/07/2025$0.68$0.65-3.99%$0.72$0.61281,323 shs$35.75 million04/04/2025$0.71$0.68-4.67%$0.71$0.66186,390 shs$37.23 million04/03/2025$0.79$0.71-10.05%$0.76$0.71154,610 shs$39.06 million04/02/2025$0.77$0.79+2.19%$0.80$0.74218,162 shs$43.42 million04/01/2025$0.77$0.77+0.04%$0.87$0.76262,175 shs$42.49 million03/31/2025$0.80$0.77-3.71%$0.87$0.751.03 million shs$42.47 million Related Companies Neurogene Stock Price Chart Genfit Stock Price Chart Eledon Pharmaceuticals Stock Price Chart Voyager Therapeutics Stock Price Chart Tevogen Bio Stock Price Chart Kodiak Sciences Stock Price Chart Canopy Growth Stock Price Chart Esperion Therapeutics Stock Price Chart INmune Bio Stock Price Chart Inhibrx Stock Price Chart Receive PRLD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRLD) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prelude Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Prelude Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRLD Stock Free PRLD Stock Alerts